Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015

Details for Mechanism ID: 9541
Country/Region: Uganda
Year: 2015
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $722,394 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $722,394
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 5,169
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 16,120
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 528
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 1,633
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 10,117
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 31,463
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 626
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 1,942
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 16,440
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 51,158
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 16,440
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 51,158
CARE_NEW Aggregated Age/sex: <15 Female 2016 118
CARE_NEW Aggregated Age/sex: <15 Male 2016 104
CARE_NEW Aggregated Age/sex: 15+ Female 2016 1,990
CARE_NEW Aggregated Age/sex: 15+ Male 2016 1,063
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 3,275
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 3,275
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 3,275
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 31
PMTCT_EID By infants who received a virologic test within 2 months of birth 2016 3,835
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 420
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 4,257
PMTCT_EID Sum of Infant Age disaggregates 2016 4,255
TB_ART Aggregated Age: <15 2016 62
TB_ART Aggregated Age: 15+ 2016 755
TB_ART Female 2016 525
TB_ART Male 2016 292
TB_ART Sum of Aggregated Age disaggregates 2016 817
TB_ART Sum of Sex disaggregates 2016 817
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 817
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 3,586
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 47,661
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 16,440
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 51,158
TB_SCREEN Sex: Female 2016 33,471
TB_SCREEN Sex: Male 2016 17,776
TB_SCREEN Sum of Aggregated Age disaggregates 2016 51,247
TB_SCREEN Sum of Sex disaggregates 2016 51,247
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 51,247
TX_CURR Aggregated Age/Sex: 15+ Female 2016 4,487
TX_CURR Aggregated Age/Sex: 15+ Female 2016 13,983
TX_CURR Aggregated Age/Sex: 15+ Male 2016 9,884
TX_CURR Aggregated Age/Sex: 15+ Male 2016 30,259
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 15,515
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 14,371
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 44,242
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 14,371
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 44,242
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 2,576
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 5,450
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 8,374
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 8,026
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 11,929
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 14,022
VMMC_AE Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2016 72
VMMC_CIRC By circumcision technique: Device-based VMMC 2016 2,133
VMMC_CIRC By circumcision technique: Surgical VMMC 2016 19,168
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2016 21,296
VMMC_CIRC By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2016 4,687
VMMC_CIRC By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2016 16,228
VMMC_CIRC By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2016 384
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2016 21,296
Cross Cutting Budget Categories and Known Amounts Total: $40,000
Gender: Gender Equality $10,000
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Key Populations: Sex Workers $10,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Condoms: Policy, Tools, and Services $20,000